PET and MRI Imaging With Scopolamine at the Muscarinic M1 Receptor
Condition(s):Muscarinic Receptor OccupancyLast Updated:February 29, 2024Not yet recruiting
Hide Studies Not Open or Pending
Condition(s):Muscarinic Receptor OccupancyLast Updated:February 29, 2024Not yet recruiting
Condition(s):Healthy VolunteersLast Updated:August 30, 2021Completed
Condition(s):COPD ExacerbationLast Updated:February 9, 2024Recruiting
Condition(s):Apparent Life-Threatening Event in Infants Under One Year of AgeLast Updated:June 30, 2022Recruiting
Condition(s):Sjogren’s Syndrome; Overactive Bladder SyndromeLast Updated:August 10, 2021Unknown status
Condition(s):AsthmaLast Updated:April 20, 2016Completed
Condition(s):COPD; COPD ExacerbationLast Updated:February 20, 2024Completed
Condition(s):Chronic Obstructive Pulmonary DiseaseLast Updated:July 18, 2023Active, not recruiting
Condition(s):Schizophrenia; Schizophreniform DisordersLast Updated:February 26, 2024Not yet recruiting
Condition(s):Schizophrenia; Schizoaffective Disorder; HealthyLast Updated:March 22, 2024Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.